The AIM4 Next Step study: Comparing inhaled corticosteroid dose escalation to dupilumab in patients with uncontrolled asthma and type 2 inflammation.
- DOI
- 10.1016/j.jacig.2026.100718
- Published
- 2026 Jul
- Container
- The journal of allergy and clinical immunology. Global
- Publisher
- Not recorded
- Open access
- yes
Credibility signals
limited evidence Score 45/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.
Show all credibility signals
- cautionDOI registered: No matching Crossref record was present in this response.
- cautionDOI resolves: No matching Crossref record was present in this response.
- not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility.
- not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made.
- not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made.
- not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made.
- not scoredROR affiliation: Not checked or no result supplied; no credibility inference made.
- not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- supportingOpen access status: Normalized open-access status: open.
- not scoredPublication license: Not checked or no result supplied; no credibility inference made.
- not scoredPublication version: A publication version was supplied but is not scored.
- cautionMetadata completeness: 5 of 6 scored descriptive metadata groups are present; missing fields increase uncertainty.
Cite this work
BibTeX
@article{allodium:10.1016/j.jacig.2026.100718,
title = {The AIM4 Next Step study: Comparing inhaled corticosteroid dose escalation to dupilumab in patients with uncontrolled asthma and type 2 inflammation.},
author = {Busse WW and Iammatteo M and Soliman M and Lugogo NL and Bacharier LB and O'Byrne PM and Bourdin A and Katial RK and Mosnaim GS and Peters AT and Korn S and Xia C and Ledanois O and Martin A and Sacks HJ and Deniz Y},
year = {2026},
journal = {The journal of allergy and clinical immunology. Global},
doi = {10.1016/j.jacig.2026.100718},
url = {https://doi.org/10.1016/j.jacig.2026.100718}
}RIS
TY - JOUR TI - The AIM4 Next Step study: Comparing inhaled corticosteroid dose escalation to dupilumab in patients with uncontrolled asthma and type 2 inflammation. AU - Busse WW AU - Iammatteo M AU - Soliman M AU - Lugogo NL AU - Bacharier LB AU - O'Byrne PM AU - Bourdin A AU - Katial RK AU - Mosnaim GS AU - Peters AT AU - Korn S AU - Xia C AU - Ledanois O AU - Martin A AU - Sacks HJ AU - Deniz Y PY - 2026 JO - The journal of allergy and clinical immunology. Global DO - 10.1016/j.jacig.2026.100718 UR - https://doi.org/10.1016/j.jacig.2026.100718 ER -
APA
WW, B., M, I., M, S., NL, L., LB, B., PM, O., A, B., RK, K., GS, M., AT, P., S, K., C, X., O, L., A, M., HJ, S., & Y, D. (2026). The AIM4 Next Step study: Comparing inhaled corticosteroid dose escalation to dupilumab in patients with uncontrolled asthma and type 2 inflammation.. The journal of allergy and clinical immunology. Global. https://doi.org/10.1016/j.jacig.2026.100718
Source records
- pubmed · retrieved 2026-09-26T04:37:42.820Z